Mesenchymal iron deposition is associated with adverse long‐term outcome in non‐alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Mesenchymal iron deposition is associated with adverse long‐term outcome in non‐alcoholic fatty liver disease

Published:2020-05-28 Issue:8 Volume:40 Page:1872-1882
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Eder Sebastian K.¹²^ORCID,Feldman Alexandra¹,Strebinger Georg¹,Kemnitz Jana³,Zandanell Stephan¹^ORCID,Niederseer David⁴⁵,Strasser Michael¹,Haufe Heike⁶,Sotlar Karl⁶,Stickel Felix⁷,Paulweber Bernhard¹,Datz Christian⁴,Aigner Elmar¹

Affiliation:

1. First Department of Medicine Paracelsus Medical University Salzburg Austria

2. Department of Pediatrics and Adolescent Medicine St. Anna Children's Hospital Medical University of Vienna Vienna Austria

3. Department of Imaging & Functional Musculoskeletal Research Institute of Anatomy & Cell Biology Paracelsus Medical University Salzburg Austria

4. Department of Internal Medicine Hospital Oberndorf Teaching Hospital of the Paracelsus Medical University Salzburg Oberndorf Austria

5. Department of Cardiology University Heart Center Zurich University Hospital Zurich Zurich Switzerland

6. Institute of Pathology Paracelsus Medical University Salzburg Austria

7. Department of Gastroenterology and Hepatology University Hospital Zurich Zurich Switzerland

Funder

Paracelsus Medizinische Privatuniversität

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14503

Reference38 articles.

1. Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

2. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

3. Liver fibrosis, but no other histologic features, is associated with long‐term outcomes of patients with nonalcoholic fatty liver disease;Angulo P;Gastroenterology,2015

4. Association between non-alcoholic fatty liver disease and cancer incidence rate

5. Iron overload and non‐alcoholic fatty liver disease;Datz C;Minerva Endocrinol,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatty Liver Disease;MacSween's Pathology of the Liver;2024

2. Targeting PKC alleviates iron overload in diabetes and hemochromatosis;2023-11-29

3. Secondary Iron Overload and the Liver: A Comprehensive Review;Journal of Clinical and Translational Hepatology;2023-02-01

4. Iron as a therapeutic target in chronic liver disease;World Journal of Gastroenterology;2023-01-28

5. Recent advances in the application of ionomics in metabolic diseases;Frontiers in Nutrition;2023-01-16